Combined α fetoprotein testing and ultrasonography as a screening test for primary liver cancer

Journal of Medical Screening

Volumn 6, Issue 2, 1999, Pages 108-110

  Zhang, Boheng ^a   Yang, Binghui ^a,b  

^a FUDAN UNIVERSITY   (China)

^b Department of Medicine ^*

Author keywords

Cost effectiveness; Primary liver cancer

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; ARTICLE; CANCER SCREENING; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; HEALTH CARE COST; HEPATITIS; HUMAN; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTION;

EID: 0032993424     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.2.108     Document Type: Article

References (6)

1. Li L, Zhang S, Lu F, et al. Research on characteristics of mortality spectrum and type composition of malignant tumors in China. Chinese Journal of Oncology 1997;19:323-8.
2. Yang B, Zhang B, Xu Y, et al. Prospective study of early detection for primary liver cancer. J Cancer Res Clin Oncol 1997;123:357-60.
3. Tang ZY. Primary liver cancer. In: Tang ZY, ed. Current oncology. Shanghai: Shanghai Medical University Press; 1993:553-85.
4. Izzo F, Cremona F, Ruffolo F, et al. Outcome of 67 patients with hepatocellular cancer detected druing screening of 1125 patients with chronic hepatitis. Ann Surg 1998;227: 513-18.
5. Mima S, Sekiya C, Kanagawa H, et al. Mass screening for hepatocellular carcinoma: experience in Hokkaido, Japan. J Gastroenterol Hepatol 1994;9:361-5.
6. Kang JY, Lee TP, Yap I, et al. Analysis of cost-effectiveness of different strategies for hepatocellular carcinoma screening in hepatitis B virus carriers. J Gastroenterol Hepatol 1992; 7:463-8.